Both of these markers of brain injury were significantly re-
Recent evidence suggests that inflammatory processes in the brain play a crucial role in the pathogenesis of cerebral ischemia. Accordingly, animal studies of both global and focal cerebral ischemia have shown that pro inflammatory cytokine expression is increased (Beamer et aI., 1995; Liu et aI., 1993; Minami et aI., 1992; Szaflarski et aI., 1995) and resident microglia are acti vated after an ischemic insult (Gehrmann et aI., 1995; Gehrmann et aI., 1992) . Furthermore, infiltration of peripheral immune cells appears to be involved because the ischemic brain is protected by depletion of blood leukocytes and blocking vascular adhesion molecules (Chopp et aI., 1994; Hallenbeck, 1996) . A role for the pro inflammatory cytokine, interleukin-l beta duced in the ICE KG mice as compared to wild-type C57BLl6 mice. Regional cerebral blood tlow, determined using the tlow tracer, N-isopropyl [methyl I ,3_14C] p-iodoamphetamine e4C IMP), was similar in the two strains of mice, indicating that the reduced brain injury in the KG mice was not a result of a lesser degree of ischemia. These data show that ICE contributes to the development of ischemic brain damage, and that it plays a role at an early time in the pathologic process. Although the mecha nism of this effect is uncertain, our results suggest that phar macologic inhibition of ICE may be a useful treatment for stroke. Key Words: Cerebral ischemia-Interleukin-l�
Converting Enzyme-Edema. has been demonstrated by the findings that the endog enous IL-I receptor antagonist (IL-Ira) (Betz et aI., 1995; Relton and Rothwell, 1992 ) and a neutralizing an tibody to IL-113 (Yamasaki et aI., 1995) both reduce brain damage and edema when administered before a stroke in rats.
Biologically active IL-113 is formed by the enzymatic cleavage of inactive proIL-ll3 by the protease, IL-113 converting enzyme (ICE). ICE is a member of a family of cysteine proteases, the caspases, several of which are associated with the apoptotic cell death pathway. This pathway has been implicated in ischemic brain damage (Linnik et aI., 1993) . Thus, inhibition of ICE could be a viable strategy for reducing brain damage after a stroke due to its role in IL-113 formation and neuroinflamma tion, or apoptosis, or both. Testing this hypothesis has been difficult because selective ICE inhibitors have been unavailable. Recently, mutant mice, deficient in a func tional gene for ICE have been produced (Kuida et aI., 1995; Li et aI., 1995a) . In the present study we tested the hypothesis that these mutant mice, being unable to pro duce mature IL-ll3, would have less brain damage than their wild-type controls in response to a focal ischemic insult.
MATERIALS AND METHODS

Ischemia in ICE knockout and C57BLl6 mice
Three independent studies, measuring histologic lesion size, regional CBF (rCBF) and brain edema formation after perma nent middle cerebral artery occlusion (MCAO), were per formed using male, 23 to 30 g, ICE knockout (KO) and C57BLl6 mice. The ICE-deficient mutant mice were created and characterized by the BASF Corporation, Worcester, MA (Li et aI., 1995a) . These mice contain a null mutation in the ICE gene that was generated by homologous recombination in em bryonic stem cells. C57BLl6 mice were obtained from Jackson Labs, Bar Harbor, ME. Focal cerebral ischemia was induced by MCAO using the suture model as described previously (Yang et aI., 1994) .
Lesion size
The volume of ischemic brain damage after MCAO was 
Regional CBF
rCBF was determined in seven KO and seven C57BLKl6 mice 30 minutes after MCAO using a modification of the in dicator fractionation technique described previously (Betz and Iannotti, 1983; Van Uitert and Levy, 1978) . Mice were anes thetized with chloralhydrate and a cannula was placed in the femoral artery for blood sampling. Core body temperature was maintained at 37°C to 38°C by a feedback controlled heating pad. The middle cerebral artery (MCA) was occluded as de scribed above. Thirty minutes later, I J.LCi of the t10w tracer, (Obrenovitch et aI., 1987) in 100 J.LL of 0.9% saline was in jected into the jugular vein and, simultaneously, a peristaltic pump was started to withdraw blood at a rate of 100 J.LLlmin.
After I minute of isotope circulation, the pump was stopped, the mouse killed immediately, and brain sampled by region for isotope counting. Cortex, basal ganglia, and blood samples were digested in methylbenzethonium hydroxide (Sigma, St.
Louis, MO, U.S.A.), and prepared for liquid scintillation count ing (Beckman 3801 scintillation counter, Beckman, Schaum burg, IL, U.S.A.). rCBF was calculated from tissue and blood radioactivity and expressed as mLiIOO g/min.
Brain edema
Brain water content was measured in six KO and six C57BLKl6 mice, 4 hours after MCAO. Mice were anesthetized with isot1urane (1.5% to 2%) supplemented with oxygen. A cannula was placed in the femoral artery for measurement of blood pressure and sampling of blood for determination of pC02, p02 and pH. The MCA was occluded as described above and the mice maintained under anesthesia for 4 hours, after which the brains were sampled for determination of brain water content by the wet/dry weight method. Cortical and basal gan glion samples were weighed and then dried to constant weight for 24 hours at 100°C. After reweighing, these samples were dissolved in nitric acid for determination of sodium and potas sium content by t1ame photometry. Two wild-type mice were eliminated from the study because their blood pH was less than 7.10.
Statistical methods
Results are expressed as mean ± SD. Mean values were compared using the Student's t-test.
RESULTS
Brain lesion volume was determined in KO and C57BLKJ6 mice 24 hours after induction of permanent focal ischemia. The lesion volume in the KO mice was 52% smaller than that of the wild-type mice (93 ± 25 mm 3 versus 45 ± 27 mm 3 , respectively; P < .05; Fig. 1 ). laser Doppler flowmetry measurement of CBF indicated that the MCAO was successful in both groups because the CBF was reduced similarly in the KO and control mice (92% versus 93% reduction, respectively).
To determine if the protection afforded the KO mice was the result of a smaller reduction in CBF after MCAO, we used a more quantitative measure of the regional CBF in the cortex and basal ganglia, 30 minutes after MCAO. F i gure 2 shows t h at KO and C57BLKJ6 mice had similar rCBF in the nonischemic hemisphere. In the ischemic hemisphere, rCBF was reduced to 20 ± 14 and 25 ± 6 mLiIOO g/min in the cortex and 41 ± 28 and 53 ± 32 mLilOO g/min in the caudate of the controls and KO mice, respectively. These data show that rCBF was reduced to a similar extent in the mutant and control strains. Thus, the smaller brain lesions in the KO mice were not due to incomplete occlusion of the MCA or greater collateral flow capacity. The extent of ischemic brain damage can be influ enced by physiologic variables such as blood pressure and body temperature. An altered response of such criti cal processes to the ischemic event could be responsible for the smaller lesions we observed in the mutant strain at 24 hours. Therefore, we measured brain edema for mation in control and ICE-deficient mice at 4 hours after MCAO. Blood pressure, although unstable, was similar in the two groups. Body temperature was maintained at 36.SoC to 38°C. Brain water, sodium, and potassium content in the nonischemic hemisphere of control and mutant mice were similar. Water and sodium content increased and potassium content decreased in the isch emic cortex and basal ganglia of the wild-type mice. These changes were significantly blunted in the KO mice (Table 1 ). The degree of brain edema observed at 4 hours likely reflects the volume of tissue that is compromised and eventually becomes infarcted. The reduced brain edema at 4 hours in the ICE-deficient mice suggests that ICE actlvlty is contributing early in the sequence of events leading to ischemic brain injury.
DISCUSSION
This study shows that brain edema and the extent of brain damage resulting from MCAO are significantly reduced in the ICE-deficient mice compared to C57BLKl6 mice, despite similar reductions in blood flow in these two strains. In a preliminary study we also compared ischemic lesions in ICE KO and 129/SV mice, the strain from which the embryonic stem cells were derived and, thus, contributed to the genetic make-up of the KO mice. We found a similarly reduced histologic lesion in the KO mice (Betz et a!., 1996) . Because others have reported similar lesion sizes after MCAO in these two background strains (Huang et a!., 1994) , it is un likely that our findings are due to variability in the back ground strain's responses to MCAO, but rather are a result of the elimination of the ICE gene. Supporting this is the recent finding that a mutant ICE gene expressing an ICE inhibitory protein reduces lesion volume after transient focal ischemia in mice, although inhibition of other caspases cannot be ruled out in these dominant negative mutants (Friedlander et a!., 1997; Hara et a!., 1997a). Additionally, peptide fluoromethyl and chloro methyl ketones, which are nonspecific irreversible in hibitors of the ICE protease family, reduce ischemic and excitotoxic brain injury (Hara et a!., 1997 b). Our findings in mutant mice, in which the ICE gene has been selec tively eliminated, indicate that ICE (rather than its ho mologues) plays an important role in ischemic pathology in the brain. However, the precise mechanisms by which ICE contributes to the pathogenic process are still uncer tain.
Our observations are consistent with the hypothesis that the KO mice are protected from an ischemic insult because they have lower brain IL-I !3 levels. There is considerable evidence that ICE and IL-I !3/IL-I ra mRNA levels are acutely increased in cerebral ischemia (Buttini et a!., 1994; Liu et a!., 1993; Wang et a!., 1994) , in the microglia and astrocytes and endothelial cells but not neurons (Bhat et aI., 1996; Lynch et aI., 1997) . The first demonstration that IL-113 mediates ischemic brain dam age was the finding that intracerebroventricular injection of the antagonist protein, IL-I ra, reduced stroke size in rats by 50% (Loddick and Rothwell, 1996; ReIton and Rothwell, 1992) . This was confirmed in a subsequent study in which over-expression of IL-l ra in the brain was induced by intracerebroventricuIar injection of a recom binant adenovirus vector carrying the human IL-Ira cDNA, and the lesion was reduced by 60% (Betz et aI., 1995) . More recently intravenous administration of a large quantity of human recombinant IL-I ra was also found to be neuroprotective (Garcia et aI., 1995; Relton et aI., 1996) . Additionally, intracerebroventricular ad ministration of a polyclonal IL-113 neutralizing antibody reduced brain edema after focal ischemia with reperfu sion in the rat, thus indicating IL-ll3 as an important mediator of ischemic damage (Yamasaki et aI., 1995) . Although it is reasonable to assume that in the ICE KO mice little proIL-I 13 is processed, it is conceivable that the brain could produce biologically active IL-113 through an alternative pathway induced during ischemia. Brain tissue IL-ll3 levels were not measured in this study because the available antibodies are not sufficiently se lective for biologically active mature IL-113 over proIL-113 and Western blot analysis is not sensitive enough to detect brain levels (unpublished data, K. Wang and R. Nath, November 1996). However, macrophages isolated from these ICE KO mice do not produce IL-ll3 when stimulated by the proinflammatory endotoxin, lipopoly saccharide (Li et aI., 1995a) . Additionally, KO mice are protected from the shock induced by this endotoxin and no IL-ll3 is detected in their plasma.
IL-ll3 is a proinflammatory cytokine with numerous actions in the brain that could account for its influence on ischemic brain damage. For example, brain temperature is a critical variable in ischemia studies and IL-113 is pyrogenic (Klir et aI., 1994; Smith and Kluger, 1992) . However, in the present study, and in the rat MCAO studies with IL-1 ra, reduced body temperature appears not to be the cause of the observed neuroprotection. Other actions of IL-ll3 include microglial activation, in duction of leucocyte adhesion molecules, stimulation of infiltration of inflammatory cells, and induction several other cytokines and mediators such as IL-6, arachidonic acid, nitric oxide, amyloid precursor protein, and corti cotrophin-releasing factor (Dinarello, 1996) . Many of the central actions of IL-II3, such as its effects on tempera ture regulation, are mediated through the prostaglandins and are blocked by cyclo-oxygenase inhibitors. Several of these biochemical pathways may generate potentially harmful free radicals that could contribute to ischemic brain damage. Thus, there are many mechanisms that could explain how decreased ICE activity and the subsequent reduction in brain IL-ll3 could influence the out come from an ischemic insult (Rothwell and Hopkins, 1995) . In addition, other substrates for ICE may exist (Gu et aI., 1997) whose product may contribute to isch emic brain injury. Moreover, our studies in ICE KO mice cannot exclude as candidate protective mechanisms, compensatory changes that may have occurred during development.
Because ICE is a member of a family of cysteine proteases (caspases) that has been implicated in apop totic cell death (Yuan et a!., 1993) and apoptosis may occur in brain ischemia (Li et aI., 1995b; Linnik et a!., 1993; van Lookeren Campagne and Gill, 1996) , the pos sibility that our findings in the ICE KO mice might be due to interference with an apoptotic process should be considered. The two known functions of ICE itself are cleaving of the inactive 31-kd proIL-ll3 to the active 17 -kd IL-113 and processing pro-interferon gamma inducing factor. Nonetheless, ICE has been implicated in apoptosis by several in vitro studies in non-neuronal and neuronal models of apoptotic cell death. For example, when ICE is over-expressed in rat fibroblasts, apoptosis is stimulated (Miura et a!., 1993) . This and several other in vitro apoptosis models can be affected by pharmaco logic ICE inhibitors (Enari et aI., 1995; Milligan et aI., 1995) . However, these inhibitors lack selectivity be tween ICE and other members of the caspase family, making it difficult to pinpoint ICE in the apoptotic pro cess. Such specificity is achieved in the ICE KO mice that have normal CNS structure and cell number. This apparently normal phenotype suggests that ICE is not required for the apoptosis that occurs naturally during development. In vitro, macrophages from KO and wild type mice both undergo apoptosis when stimulated with ATP (Li et a!., I995a) . Similarly, KO thymocytes that are treated with dexamethasone or gamma irradiation undergo normal apoptosis. The exceptions to this pattern are that Fas-mediated killing of thymocytes is reduced in thymocytes isolated from KO mice (Kuida et a!., 1995) as is apoptotic death in dorsal root ganglion cultures after growth factor withdrawal (Friedlander et aI., 1997) . In addition, some studies show that ICE is not expressed in neurons (Bhat et a!., 1996; Lynch et aI., 1997) , even when the brain is challenged by global forebrain isch emia or lipopolysaccharide and expression is increased in astrocytes and microglia (Vasilakos et aI., 1995) . However, it is still unknown whether or not ICE is ex pressed in neurons after a focal ischemic insult.
Thus, it is still uncertain if ICE-deficient mice are protected from ischemic damage by a reduced apoptotic response, and therefore our findings should not be inter preted as evidence that apoptosis is important in isch emic brain injury. However, considering the evidence showing a role for IL-ll3 in cerebral ischemia, it is pos sible that IL-ll3 permits or stimulates apoptosis. A recent study supports a role for IL-113 as a potentiating factor in apoptotic death in culture. (Friedlander et aI., (996) .
In conclusion, our results show that ICE plays an im portant role in ischemic brain damage. It is likely that this effect is due to a reduced production of IL-I I3, al though the precise mechanism is not known. Regardless of the mechanism, this study suggests that selective in hibitors of ICE would be valuable for the treatment of stroke.
